Annual ROE
-43.94%
-28.48%-184.22%
December 31, 2024
Summary
- As of March 10, 2025, BEAM annual return on equity is -43.94%, with the most recent change of -28.48% (-184.22%) on December 31, 2024.
- During the last 3 years, BEAM annual ROE has risen by +25.19% (+36.44%).
- BEAM annual ROE is now -184.22% below its all-time high of -15.46%, reached on December 31, 2023.
Performance
BEAM ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-44.08%
-27.46%-165.22%
December 31, 2024
Summary
- As of March 10, 2025, BEAM quarterly return on equity is -44.08%, with the most recent change of -27.46% (-165.22%) on December 31, 2024.
- Over the past year, BEAM quarterly ROE has stayed the same.
- BEAM quarterly ROE is now -177.93% below its all-time high of -15.86%, reached on March 31, 2024.
Performance
BEAM Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
BEAM ROE Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -184.2% | 0.0% |
3 y3 years | +36.4% | 0.0% |
5 y5 years | +34.1% | 0.0% |
BEAM ROE Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -184.2% | +36.4% | -177.9% | +31.1% |
5 y | 5-year | -184.2% | +60.9% | -177.9% | +67.2% |
alltime | all time | -184.2% | +60.9% | -177.9% | +67.2% |
Beam Therapeutics ROE History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | -43.94%(+184.2%) | -44.08%(+165.2%) |
Sep 2024 | - | -16.62%(+0.8%) |
Jun 2024 | - | -16.48%(+3.9%) |
Mar 2024 | - | -15.86%(-2.6%) |
Dec 2023 | -15.46%(-58.3%) | -16.29%(-60.5%) |
Sep 2023 | - | -41.27%(-3.6%) |
Jun 2023 | - | -42.81%(+3.9%) |
Mar 2023 | - | -41.20%(+11.3%) |
Dec 2022 | -37.06%(-46.4%) | -37.03%(-5.5%) |
Sep 2022 | - | -39.19%(+29.3%) |
Jun 2022 | - | -30.32%(-11.4%) |
Mar 2022 | - | -34.23%(-46.5%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2021 | -69.13%(-38.5%) | -63.97%(-27.6%) |
Sep 2021 | - | -88.40%(-28.6%) |
Jun 2021 | - | -123.75%(-7.9%) |
Mar 2021 | - | -134.42%(+43.5%) |
Dec 2020 | -112.32%(+68.5%) | -93.66%(+35.7%) |
Sep 2020 | - | -69.01%(+6.9%) |
Jun 2020 | - | -64.58%(+4.1%) |
Mar 2020 | - | -62.06%(-1.9%) |
Dec 2019 | -66.67%(-22.5%) | -63.28%(+12.7%) |
Sep 2019 | - | -56.14%(-38.4%) |
Jun 2019 | - | -91.09%(+12.4%) |
Mar 2019 | - | -81.03%(+14.3%) |
Dec 2018 | -85.99% | -70.88% |
FAQ
- What is Beam Therapeutics annual return on equity?
- What is the all time high annual ROE for Beam Therapeutics?
- What is Beam Therapeutics annual ROE year-on-year change?
- What is Beam Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Beam Therapeutics?
- What is Beam Therapeutics quarterly ROE year-on-year change?
What is Beam Therapeutics annual return on equity?
The current annual ROE of BEAM is -43.94%
What is the all time high annual ROE for Beam Therapeutics?
Beam Therapeutics all-time high annual return on equity is -15.46%
What is Beam Therapeutics annual ROE year-on-year change?
Over the past year, BEAM annual return on equity has changed by -28.48% (-184.22%)
What is Beam Therapeutics quarterly return on equity?
The current quarterly ROE of BEAM is -44.08%
What is the all time high quarterly ROE for Beam Therapeutics?
Beam Therapeutics all-time high quarterly return on equity is -15.86%
What is Beam Therapeutics quarterly ROE year-on-year change?
Over the past year, BEAM quarterly return on equity has changed by 0.00% (0.00%)